Question 1

What is the catalog number for N-[4- ((2-Oxo-1,2-dihydroquinolin-7-yl) oxy) butyl] Brexpiprazole?

Accepted Answer

The catalog number for N-[4- ((2-Oxo-1,2-dihydroquinolin-7-yl) oxy) butyl] Brexpiprazole is 457754.

Question 2

What sizes are available for N-[4- ((2-Oxo-1,2-dihydroquinolin-7-yl) oxy) butyl] Brexpiprazole?

Accepted Answer

N-[4- ((2-Oxo-1,2-dihydroquinolin-7-yl) oxy) butyl] Brexpiprazole is available in the following size(s): 1 mg, 2 mg.

Question 3

How many pack sizes does N-[4- ((2-Oxo-1,2-dihydroquinolin-7-yl) oxy) butyl] Brexpiprazole come in?

Accepted Answer

N-[4- ((2-Oxo-1,2-dihydroquinolin-7-yl) oxy) butyl] Brexpiprazole is available in 2 different pack sizes.

Question 4

Is N-[4- ((2-Oxo-1,2-dihydroquinolin-7-yl) oxy) butyl] Brexpiprazole in stock?

Accepted Answer

N-[4- ((2-Oxo-1,2-dihydroquinolin-7-yl) oxy) butyl] Brexpiprazole is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is the molecular weight of the target protein?

Accepted Answer

Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.

Question 6

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

Question 7

What is the recommended dilution for this antibody?

Accepted Answer

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

N-[4- ((2-Oxo-1,2-dihydroquinolin-7-yl) oxy) butyl] Brexpiprazole

Product Specifications

Available Sizes

Frequently Asked Questions

Explore Other Products

TGF-beta (1D11.16.8), CF647 conjugate, 0.1mg/mL

CD45 / LCA (2B11 + PD7/26), CF770 conjugate, 0.1mg/mL

CD45 / LCA (B-Cell Marker) (rPTPRC/1460), CF488A conjugate, 0.1mg/mL

Human Kappa Light Chain (HP6053 + L1C1), CF405S conjugate, 0.1mg/mL

Von Willebrand Factor / Factor VIII Related-Ag (Endothelial Marker) (VWF/1859R), CF488A conjugate, 0.1mg/mL

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma) (BARX1/2759), CF640R conjugate, 0.1mg/mL